changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
Providing innovative products that enable specialist physicians to serve their patients better – focusing on Interventional Medicine therapies and Pharmaceuticals for acute care uses
We develop products used in minimally invasive procedures to treat or provide symptomatic relief for people with cancer and benign tumours, targeting diseased cells while decreasing the impact on healthy tissue.
Our Interventional Pulmonology business is dedicated to supporting clinicians in improving the lives of patients who suffer from severe emphysema.
We help interventional vascular teams to solve problems with patients’ veins and arteries.
We focus on antidote products that are used in emergency rooms and intensive care units. We provide antidotes to counteract snake venom and the toxicity associated with some heart and cancer medications.
Named patient supply enables healthcare professionals, on behalf of their patients, to access medicines approved or nearing approval in other countries before marketing authorisation has been granted in their home country.
Inspired by a deep understanding of our customers’ needs, we’re working to meaningfully improve the lives of patients and their healthcare experience.
Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com